Wendy B London

Wendy B London

UNVERIFIED PROFILE

Are you Wendy B London?   Register this Author

Register author
Wendy B London

Wendy B London

Publications by authors named "Wendy B London"

Are you Wendy B London?   Register this Author

100Publications

2983Reads

40Profile Views

Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.

J Pediatr 2019 Aug 15;211:152-158. Epub 2019 May 15.

Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, CA; Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2019.04.017DOI Listing
August 2019

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatr Blood Cancer 2019 Aug 21;66(8):e27819. Epub 2019 May 21.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27819DOI Listing
August 2019

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.

JCO Clin Cancer Inform 2018 12;2:1-15

Arlene Naranjo, University of Florida, Gainesville, FL; Meredith S. Irwin, Hospital for Sick Children, Toronto, ON, Canada; Michael D. Hogarty, University of Pennsylvania, Philadelphia, PA; Susan L. Cohn, The University of Chicago, Chicago, IL; Julie R. Park, University of Washington, Seattle, WA; and Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421832PMC
December 2018

Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.

J Am Acad Dermatol 2018 Aug 26;79(2):230-237. Epub 2018 Mar 26.

Harvard Medical School, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2018.03.029DOI Listing
August 2018

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

J Neurooncol 2017 Oct 21;135(1):201-211. Epub 2017 Jul 21.

Pediatric Neuro-Oncology Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2568-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658456PMC
October 2017

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

Reply to J. Stenman et al.

J Clin Oncol 2017 06 19;35(17):1966-1967. Epub 2017 Apr 19.

Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center, New York, NY; Daphne Haas-Kogan, Harvard Medical School, Boston, MA; Julie Park, University of Washington, Seattle, WA; Susan G. Kreissman, Duke Medical Center, Durham, NC; Daniel von Allmen, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Andrew Davidoff, St Jude Children's Research Hospital, Memphis, TN; Wendy B. London, Children's Hospital Boston/Dana-Farber Cancer Institute, Boston, MA; and Geetika Khanna, Mallinckrodt Institute of Radiology, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2777DOI Listing
June 2017

A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.

Cancer Res 2017 02 6;77(4):971-981. Epub 2016 Dec 6.

Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales Australia, Kensington, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-2906DOI Listing
February 2017

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Eur J Cancer 2017 02 26;72:177-185. Epub 2016 Dec 26.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258837PMC
February 2017

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.

Int J Radiat Oncol Biol Phys 2017 02 8;97(2):270-277. Epub 2016 Nov 8.

Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.10.047DOI Listing
February 2017

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma.

J Clin Oncol 2017 Jan 21;35(2):208-216. Epub 2016 Nov 21.

Daniel von Allmen, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Andrew M. Davidoff, St Jude Children's Research Hospital, Memphis, TN; Wendy B. London, Boston Children's Hospital; Wendy B. London and Daphne A. Haas-Kogan, Dana-Farber Cancer Institute; Harvard Medical School; and Daphne A. Haas-Kogan, Brigham and Women's Hospital, Boston, MA; Collin Van Ryn, University of Florida Health Science Center, Gainesville, FL; Susan G. Kreissman, Duke University School of Medicine, Durham, NC; Geetika Khanna, Washington University School of Medicine, St Louis, MO; Nancy Rosen, Quality Assurance Review Committee, Providence, RI; Julie R. Park, University of Washington School of Medicine; Seattle Children's Hospital, Seattle, WA; Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center; Weill Cornell Medical School, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2642DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455676PMC
January 2017

Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.

Biol Blood Marrow Transplant 2016 07 8;22(7):1275-1283. Epub 2016 May 8.

Stem Cell Transplantation Program, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute, Boston, Massachusetts; Boston Children's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491305PMC
July 2016

Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation.

J Pediatr Adolesc Gynecol 2016 Jun 23;29(3):265-8. Epub 2015 Oct 23.

Department of Radiation Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpag.2015.10.013DOI Listing
June 2016

End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant.

Biol Blood Marrow Transplant 2016 06 20;22(6):1049-1055. Epub 2016 Feb 20.

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.02.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541943PMC
June 2016

Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.

Pediatr Blood Cancer 2016 Apr 6;63(4):671-6. Epub 2016 Jan 6.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755789PMC
April 2016

A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell Transplantation.

Photomed Laser Surg 2016 Apr 16;34(4):178-84. Epub 2016 Mar 16.

3 Division of Pediatric Hematology-Oncology, Dana-Farber Cancer Institute/Boston Children's Hospital , Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pho.2015.4021DOI Listing
April 2016

Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study.

Pediatr Blood Cancer 2016 Jan 23;63(1):105-11. Epub 2015 Sep 23.

Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25762DOI Listing
January 2016

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

J Clin Oncol 2015 Sep 24;33(27):3008-17. Epub 2015 Aug 24.

Navin R. Pinto, Mark A. Applebaum, Samuel L. Volchenboum, and Susan L. Cohn, Comer Children's Hospital, University of Chicago, Chicago, IL; Katherine K. Matthay, University of California San Francisco (UCSF) Benioff Children's Hospital, UCSF School of Medicine, San Francisco, CA; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Peter F. Ambros, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Saga Medical Center Koseikan, Saga, Japan; Frank Berthold, Children's Hospital, University of Cologne, Koln, Germany; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; Julie R. Park, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; and Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/27/3008.full.pdf
Web Search
http://200.40.135.66:90/toc/0873/2015/0873-20150920-27-07.pd
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.4648
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.4648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567703PMC
September 2015

Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2015 May 7;21(5):913-9. Epub 2015 Feb 7.

Pediatric Stem Cell Transplantation Center, Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.027DOI Listing
May 2015

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.

Pediatr Dev Pathol 2014 Nov-Dec;17(6):441-9. Epub 2014 Sep 10.

1 Department of Pathology & Laboratory Medicine, Children's Hospital Los Angeles, and University of Southern California Keck School of Medicine, 4650 Sunset Boulevard, MS #43, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2350/14-06-1505-OA.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340697PMC
March 2015

Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families.

Biol Blood Marrow Transplant 2015 Feb 23;21(2):312-8. Epub 2014 Oct 23.

Department of Medicine, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Center for Outcomes and Population Research, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.016DOI Listing
February 2015

Voriconazole phototoxicity in children: a retrospective review.

J Am Acad Dermatol 2015 Feb 3;72(2):314-20. Epub 2014 Dec 3.

Harvard Medical School, Boston, Massachusetts; Dermatology Program, Division of Allergy and Immunology, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.10.023DOI Listing
February 2015

Reply to N.-K.V. Cheung et al.

J Clin Oncol 2014 Dec 17;32(36):4174-5. Epub 2014 Nov 17.

University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.7006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142206PMC
December 2014

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

Pediatr Blood Cancer 2014 Nov 7;61(11):1932-9. Epub 2014 Jul 7.

Department of Hematology/Oncology, Children's National Medical Center, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25134DOI Listing
November 2014

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Cancer Cell 2014 Nov 10;26(5):682-94. Epub 2014 Nov 10.

Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2014.09.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269829PMC
November 2014

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

J Clin Oncol 2014 Oct 25;32(28):3169-76. Epub 2014 Aug 25.

Kieuhoa T. Vo, Katherine K. Matthay, John Neuhaus, and Steven G. DuBois, Benioff Children's Hospital and University of California, San Francisco, San Francisco; Doug Miniati, Kaiser Permanente Medical Center, Roseville, CA; Wendy B. London, Children's Oncology Group Statistics and Data Center and Dana-Farber Children's Hospital Cancer Center, Boston, MA; Barbara Hero, Children's Hospital, University of Cologne, Köln, Germany; Peter F. Ambros, Children's Cancer Research Institute, St Anne Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Chiba Cancer Center Research Institute and Chiba University, Chiba, Japan; Kate Wheeler, Oxford Children's Hospital, Oxford; Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Susan L. Cohn, The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/08/25/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.1621
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.1621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171360PMC
October 2014

A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.

N Engl J Med 2014 Oct;371(15):1407-17

From the Departments of Biotherapy (S.H.-B.-A., J. Blondeau, L.C., F.T., M.C.) and Immunology and Pediatric Hematology (S.B., G.C., D.M., B.N., C.P., F.T., A.F.) and the Centre d'Étude des Déficits Immunitaires (C.P.), Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), the Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, AP-HP, INSERM (S.H.-B.-A., J. Blondeau, L.C., F.T., M.C.), Unité de Technologies Chimiques et Biologiques pour la Santé, Centre National de la Recherche Scientifique, 8258-INSERM Unité 1022, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes (S.H.-B.-A.), Immunology Laboratory, Groupe Hospitalier Universitaire Paris-Sud, AP-HP, Le Kremlin-Bicêtre (S.H.-B.-A.), Imagine Institute, Paris Descartes-Sorbonne Paris Cité University (S.B., J. Blondeau, L.C., D.M., B.N., C.P., E.S., A.F., M.C.), INSERM Unités Mixtes de Recherche 1163, Laboratory of Human Lymphohematopoiesis (J. Blondeau, L.C., E.S., F.T., A.F., M.C.), Groupe Immunoscope, Immunology Department, Institut Pasteur (A.L.), and Collège de France (A.F.) - all in Paris; Division of Hematology-Oncology (S.-Y.P., H.B., D.G., C.E.H., G.H., L.E.L., W.B.L., D.A.W.) and Division of Immunology (L.D.N.), Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute (S.-Y.P., D.G., L.E.L., W.B.L., D.A.W.), Harvard Medical School (S.-Y.P., M.A., L.E.L., W.B.L., J.R., L.E.S., A.T., L.D.N., D.A.W.), Center for Human Cell Therapy, Program in Cellular and Molecular Medicine, Boston Children's Hospital (M.A., J.R., L.E.S., A.T.), Division of Hematologic Malignancies, Dana-Farber Cancer Institute (J.R.), and the Manton Center for Orphan Disease Research (L.D.N.) - all in Boston; Great Ormond Street Hospital for Children NHS Foundation Trust (H.B.G., J.X.-B., A.J.T.) and Section of Molecular and Cellular Immunology, University College London Institute of Child Health (H.B.G., K.F.B., A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1404588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274995PMC
October 2014

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database.

Pediatr Blood Cancer 2014 Jul 30;61(7):1173-9. Epub 2014 Jan 30.

Division of Pediatric Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657506PMC
July 2014

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.

Pediatr Blood Cancer 2014 Apr 13;61(4):627-35. Epub 2013 Sep 13.

Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24777DOI Listing
April 2014

Balancing education and service in graduate medical education: data from pediatric trainees and program directors.

Acad Med 2014 Apr;89(4):652-7

Dr. Kesselheim is assistant professor of pediatrics, Department of Pediatric Oncology, Dana-Farber/Children's Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. Ms. Sun is statistician, formerly with the Department of Pediatric Oncology, Dana-Farber/Children's Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. Dr. Woolf is associate professor of pediatrics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Dr. London is statistician, Department of Pediatric Oncology, Dana-Farber/Children's Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. Dr. Boyer is assistant professor of pediatrics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACM.0000000000000174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885597PMC
April 2014

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

J Clin Oncol 2014 Apr 24;32(12):1228-35. Epub 2014 Mar 24.

Daniel A. Morgenstern and Meredith S. Irwin, Hospital for Sick Children and University of Toronto; Derek Stephens, Hospital for Sick Children, Toronto, ON, Canada; Daniel A. Morgenstern, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London; Andrew D.J. Pearson, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Samuel L. Volchenboum and Susan L. Cohn, University of Chicago, Chicago, IL; Barbara Hero, University Children's Hospital, Köln, Germany; Andrea Di Cataldo, University of Catania, Catania, Italy; Akira Nakagawara, Chiba University School of Medicine, Chiba, Japan; Hiroyuki Shimada, University of Southern California at Los Angeles, Los Angeles; Katherine K. Matthay, University of California at San Francisco, San Francisco, CA; and Peter F. Ambros, St. Anna Kinderkrebsforschung, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.6342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876342PMC
April 2014

Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.

J Clin Oncol 2014 Feb 13;32(6):527-34. Epub 2014 Jan 13.

Wendy Landier, F. Lennie Wong, Jin Lee, Ola Thomas, Heeyoung Kim, and Smita Bhatia, City of Hope, Duarte; Lu Chen, Children's Oncology Group, Monrovia, CA; Kristin Knight, Oregon Health and Science University, Portland, OR; Susan G. Kreissman, Duke University Medical Center, Durham, NC; Mary Lou Schmidt, University of Illinois at Chicago, Chicago, IL; Wendy B. London, Dana-Farber/Harvard Cancer Care, Children's Hospital Boston, Boston, MA; and James G. Gurney, University of Memphis School of Public Health, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.2038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918536PMC
February 2014

Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration.

AMIA Jt Summits Transl Sci Proc 2013 18;2013:103. Epub 2013 Mar 18.

Department of Pediatrics, University of Chicago, Chicago, IL; ; Center for Research Informatics, University of Chicago, Chicago, IL;

View Article

Download full-text PDF

Source
December 2013

Predictors of neoplastic disease in children with isolated pituitary stalk thickening.

Pediatr Blood Cancer 2013 Oct 14;60(10):1630-5. Epub 2013 May 14.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24577DOI Listing
October 2013

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Pediatr Blood Cancer 2013 Jun 19;60(6):985-93. Epub 2012 Dec 19.

Seattle Children's Hospital, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA 98106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24433DOI Listing
June 2013

Effect of weight on outcomes of children undergoing hematopoietic cell transplantation.

Pediatr Hematol Oncol 2013 Mar 28;30(2):116-30. Epub 2012 Nov 28.

Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2012.743201DOI Listing
March 2013

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

J Natl Cancer Inst 2013 Feb 14;105(4):302-9. Epub 2012 Dec 14.

Section of Genetic Medicine, University of Chicago, 900 E 57th St, Rm 3220F, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691940PMC
February 2013

Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Clin Cancer Res 2012 Oct 15;18(20):5773-9. Epub 2012 Aug 15.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473162PMC
October 2012

Tumor histology during induction therapy in patients with high-risk neuroblastoma.

Pediatr Blood Cancer 2012 Sep 11;59(3):506-10. Epub 2011 Dec 11.

Department of Pediatric Hematology and Oncology, Dana-Farber Cancer Institute and Children's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24013DOI Listing
September 2012

Clinical significance of NTRK family gene expression in neuroblastomas.

Pediatr Blood Cancer 2012 Aug 11;59(2):226-32. Epub 2011 Oct 11.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258457PMC
August 2012

Overcoming reprogramming resistance of Fanconi anemia cells.

Blood 2012 Jun 27;119(23):5449-57. Epub 2012 Feb 27.

Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-408674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369681PMC
June 2012

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.

Eur J Cancer 2012 May 1;48(8):1185-91. Epub 2011 Dec 1.

Department of Paediatrics, Division of Haematology and Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049110087
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.10.037DOI Listing
May 2012

Mechanisms of CHD5 Inactivation in neuroblastomas.

Clin Cancer Res 2012 Mar 31;18(6):1588-97. Epub 2012 Jan 31.

Division of Oncology, the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306487PMC
March 2012

N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.

Cancer Res 2012 Feb 27;72(4):845-53. Epub 2011 Dec 27.

Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, Randwick, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-1885DOI Listing
February 2012